VTRS•prnewswire•
Viatris Announces Agreement to Monetize its Equity Stake in Biocon Biologics Limited
Summary
Viatris to Receive $400 Million in Cash and $415 Million in Equity Shares of Biocon Limited Transaction Accelerates the Expiration of Biosimilars Non-Compete Restrictions PITTSBURGH, Dec. 6, 2025 /PRNewswire/ -- Viatris Inc. (Nasdaq: VTRS) today announced that it has entered into...
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on December 6, 2025 by prnewswire